136
Views
1
CrossRef citations to date
0
Altmetric
Review

Postprandial insulin resistance as an early predictor of cardiovascular risk

Pages 761-770 | Published online: 24 Dec 2022

References

  • [ADA] ADA Expert Committee on the Diagnosis and Classification of Diabetes MellitusReport of the Expert Committee on the diagnosis and classification of diabetes mellitusDiabetes Care1997201183979203460
  • [ADA] ADA Expert Committee on the Diagnosis and Classification of Diabetes MellitusReport of the Expert Committee on the diagnosis and classification of diabetes mellitusDiabetes Care200326S52012502614
  • AndersonRAEvansMLEllisGRThe relationship between post-prandial lipeemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetesAtherosclerosis20011544758311166782
  • AndersonEAHoffmanRPBalonTWHyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humansJ Clin Invest1991872246522040704
  • AndersonTJMeredithITYeungACThe effect of cholesterol-lowering and antioxidant therapy on endothelial-dependent coronary vasomotionN Engl J Med1995332488937830729
  • ArnlovJLindLZetheliusBSeveral factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-upAm Heart J2001142720411579365
  • ArnlovJLindLSundstromJInsulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic dysfunction 20 years laterNutr Metab Cardiovasc Dis200515242916054547
  • AvignonARadauccanuAMonnierLNonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetesDiabetes Care199720182269405900
  • AxelsenMSmithUErikssonJWPostprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetesAnn Intern Med1999131273110391812
  • BaeJHBassengeEKimKBPostprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stressAtherosclerosis20011555172311254924
  • BelchetzPEPlantTMNakaiYHypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormoneScience19782026313100883
  • BellDSHeart failure: the frequent, forgotten, and often fatal complication of diabetesDiabetes Care20032624334112882875
  • BoSGambinoRUbertiBDoes C-reactive protein identify a subclinical metabolic disease in healthy subjects?Eur J Clin Invest2005352657015816996
  • BrownleeMBiochemistry and molecular cell biology of diabetic complicationsNature20014148131911742414
  • BruttomessoDIoriEKiwanukaEInsulin infusion normalizes fasting and post-prandial albumin and fibrinogen synthesis in type 1 diabetes mellitusDiabet Med2001189152011703437
  • CerielloAFibrinogen and diabetes mellitus. Is it time for intervention trials?Diabetologia19974073149222655
  • CerielloAThe post-prandial state and cardiovascular disease: relevance to diabetes mellitusDiabetes Metab Res Rev2000161253210751752
  • CerielloANitrotyrosine: new findings as a marker of postprandial oxidative stressInt J Clin Pract Suppl200212951812166608
  • CerielloAThe possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complicationsDiabetologia200346M91612652353
  • CerielloABortolottiNMotzEMeal-induced oxidative stress and low-density lipoprotein (LDL) oxidation in diabetes: the possible role of hyperglycemiaMetabolism1999481503810599980
  • CerielloABortolottiNMotzEMeal-generated oxidative stress in type 2 diabetic patientsDiabetes Care1998211529339727904
  • CerielloAGiuglianoDQuatraroAAnti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjectsClin Sci (Colch)199181739421662579
  • CerielloAGiuglianoDQuatraroABlood glucose may condition factor VII levels in diabetic and normal subjectsDiabetologia198831889913240844
  • CerielloATabogaCTonuttiLPost-meal coagulation activation in diabetes mellitus: the effect of AcarboseDiabetologia199639469738777997
  • CerielloAQuagliaroLPiconiLEffect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatmentDiabetes2004537011014988255
  • CharlesworthJAKriketosADJonesJEInsulin resistance and postprandial triglyceride levels in primary renal diseaseMetab Clin Exp200554821815931621
  • CorreiaNCGuarinoMPPaposoJHepatic guanylyl cyclase inhibition induces HISS-dependent insulin resistanceProc West Pharmacol Soc20024557812434528
  • DECODE Study Group on behalf of the European Diabetes Epidemiology GroupGlucose tolerance and mortality comparison of WHO and American Diabetes Association diagnostic criteriaLancet19993546172110466661
  • DECODE Study Group the European Diabetes Epidemiology GroupGlucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteriaArch Intern Med200116139740411176766
  • DECODE Study Group the European Diabetes Epidemiology GroupIs the current definition for diabetes relevant to mortality risk form all causes and cardiovascular and noncardiovascular disease?Diabetes Care2003266889612610023
  • DeFronzoRACookeCRAndresRThe effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in manJ Clin Invest197555845551120786
  • DesseinPHJoffeBIStanwixAEEditorial: Should we evaluate insulin sensitivity in rheumatoid arthritis?Sem Arth Rheum20053557
  • De VegtFDekkerJMRuheHGHyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn studyDiabetologia1999429263110491751
  • DevereuxRBRomanMJParanicasMImpact of diabetes on cardiac structure and function: the strong heart studyCirculation20001012271610811594
  • DiwadkarVAAndersonJWBridgesSRPostprandial low density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samplesProc Soc Exp Biol Med19992221788410564543
  • DokrasABochnerMHollinrakeEScreening women with polycystic ovary syndrome for metabolic syndromeObstet Gynecol2005106131715994628
  • DunnEJGrantPJType 2 diabetes: an atherothrombotic syndromeCurr Molec Med200553233215892651
  • EliassonBMeroNTaskinenM-RThe insulin resistance syndrome and postprandial lipid intolerance in smokersAtherosclerosis199712979889069521
  • EngelgauMMNarayanKMVHermanWHScreening for type 2 diabetesDiabetes Care20002315638011023153
  • FestaAD’AgostinoRJrHowardGChronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)Circulation200010242710880413
  • FishelMAWatsonSMontineTJHyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adultsArch Neurol20056215394416216936
  • FordESAbbasiFReavenGMPrevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucoseAtherosclerosis2005181143815939066
  • FrantzSCalvilloLTillmannsJRepetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α-glucosidase inhibitor acarboseFASEB J200519591315671153
  • GabouryCLSimonsonDCSeelyEWRelation of pressor responsiveness to angiotensin II and insulin resistance in hypertensionJ Clin Invest19949422953007989585
  • GriendlingKKAlexanderRWOxidative stress and cardiovascular diseaseCirculation199796326459396412
  • GuarinoMPAfonsoRARaimundoNHepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance actionAm J Physiol Gastrointest Liver Physiol2003284G5889412466146
  • GuarinoMPCorreiaNCLauttWWInsulin sensitivity is mediated by the activation of the Ach/NO/cGMP pathway in rat liverAm J Physiol Gastrointest Liver Physiol2004287G5273215331351
  • HaffnerSMThe importance of hyperglycemia in the nonfasting state to the development of cardiovascular diseaseEndocrine Rev199819583929793758
  • HanefeldMFischerSJuliusURisk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upDiabetologia1996391577838960845
  • HolmanyAYoshidaNJennischeEThe effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in ratsEur J Clin Invest19962697388957202
  • HwuCNKwokCFKuoCSExacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemiaJ Human Hypertens2002164879312080433
  • IngelssonESundstromJArnlowJInsulin resistance and risk of congestive heart failureJAMA20052943344116030278
  • KannelWBBelangerAJEpidemiology of heart failureAm Heart J199112195172000773
  • KarelisADFarajMBastardJPThe metabolically healthy but obese individual presents a favorable inflammation profileJ Clin Endocrinol Metab20059041455015855252
  • KoenigWLowelHBaumertJC-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern GermanyCirculation200410913495315023871
  • KravaritiMNakaKKKalantaridouSNPredictors of endothelial dysfunction in young women with polycystic ovary syndromeJ Clin Endocrinol Metab20059050889515985492
  • LamonteMJAinsworthBEDurstineJLInfluence of cardiorespiratory fitness on the association between C-reactive protein and metabolic syndrome prevalence in racially diverse womenJ Women’s Hlth2005142339
  • LauttWWThe HISS story overview: A novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetesCan J Physiol Pharmacol1999775536210543718
  • LauttWWPractice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: methods to quantitate mechanisms of insulin resistanceMed Res Rev20032311412424750
  • LauttWWA new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesisJ Pharmacol Sci20049591715153645
  • LauttWWLegareDJReidMAGAlcohol suppresses meal-induced insulin sensitization (MIS)Metab Synd Rel Disord20053519
  • LauttWWMacedoMPSadriPHepatic parasympathetic nerve-dependent control of peripheral insulin sensitivity is determined by feeding and fasting: dynamic control of HISS-dependent insulin actionAm J Physiol Gastrointest Liver Physiol2001281G293611408252
  • LauttWWWangXSadriPRapid insulin sensitivity test (RIST)Can J Physiol Pharmacol1998761080610326829
  • LeeWYParkJSNohWYC-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III reportInt J Cardiol200497101615336815
  • LevantesiGMacchiaAMarfisiRMMetabolic syndrome and risk of cardiovascular events after myocardial infarctionJ Am Coll Cardiol2005462778316022955
  • LevineGNFreiBKoulourisSNAscorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery diseaseCirculation1996931107138653830
  • MeroNSyvanneMTaskinenM-RPostprandial lipid metabolism in diabetesAtherosclerosis1998141S5359888643
  • MingZFanY-JYangXSynergistic protection by S-adenosylmethionine with vitamins C and E on liver injury induced by thioacetamide in ratsFree Rad Biol Med2006406172416458192
  • MollerDENew drug targets for type 2 diabetes and the metabolic syndromeNature2001414821711742415
  • MooreMCSatakeSBaranowskiBEffect of hepatic denervation on peripheral insulin sensitivity in conscious dogsAm J Physiol Endocrinol Metab2002282E2869611788359
  • NakazonoKWatanabeNMatsunoKDoes superoxide underlie the pathogenesis of hypertension?Proc Natl Acad Sci USA1991881004581658794
  • PaiJKPischonTMaJInflammatory markers and the risk of coronary heart disease in men and womenN Engl J Med2004351259961015602020
  • PatarraoRSLauttWWGuarinoMPAtropine inhibits postprandial insulin sensitivity in a dose dependent mannerDiabetologia200548A211
  • PearsonTAMensahGAAlexanderRWMarkers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart AssociationCirculation200310749951112551878
  • ReidMAGLatourMGLegareDJComparison of the rapid insulin sensitivity test (RIST), the insulin tolerance test (ITT), and the hyperinsulinemic euglycemic clamp (HIEC) to measure insulin action in ratsCan J Physiol Pharmacol2002808111812269792
  • ReidMAGLauttWWPattern of insulin delivery affects HISS action and insulin resistanceCan J Physiol Pharmacol2004821068107415644948
  • RifaiNHigh-sensitivity C-reactive protein: a useful marker for cardiovascular disease risk prediction and the metabolic syndromeClin Chem200551504515738514
  • RosenPTBallhausenTBlochWEndothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidantDiabetologia1995381157688690167
  • RutterMKMeigsJBSullivanLMC-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring StudyCirculation2004110380515262834
  • RutterMKPariseHBenjaminEJImpact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart StudyCirculation20031074485412551870
  • SadriPLauttWWBlockade of hepatic nitric oxide synthase causes insulin resistanceAm J Physiol1999277G101810409156
  • SadriPReidMAGAfonsoRAMeal-induced insulin sensitization in conscious and anesthetized rat models comparing liquid mixed meal with glucose and sucroseBr J Nutr2006952889516469144
  • SartoriMCeolottoGPapparellaIEffects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patientsAm J Hypertens2004176041015233979
  • SchchiriMKishikawaHOhkuboYLong-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patientsDiabetes Care200023B21910860187
  • ScognamiglioRNegutCVigili De KreutzenbergSPostprandial myocardial perfusion in healthy subjects and in type 2 diabetic patientsCirculation20051121798415998667
  • ShawJEHodgeAMde CourtenMIsolated post-challenge hyperglycemia confirmed as a risk factor for mortalityDiabetologia1999421050410447514
  • SimonCBrandenbergerGUltradian oscillations of insulin secretion in humansDiabetes200251S2586111815489
  • SimonCFolleniusMBrandenbergerGPostprandial oscillations of plasma glucose insulin and C-peptide in manDiabetologia198730769733322902
  • SolzbachUHornngBJeserichMVitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patientsCirculation1997961513199315540
  • SomogyiARuzicskaEBlazovicsAInsulin treatment decreases the antioxidant defense mechanism in experimental diabetesMed Sci Monit200511BR2061115990681
  • SundstromJLindLNystromNLeft ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly menCirculation2000101259560010840010
  • TakayamaSLegareDJLauttWWDose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administrationProc West Pharmacol Soc20004333411056951
  • TseTFClutterWEShahSDNeuroendocrine responses to glucose ingestion in man: specificity, temporal relationships, and quantitative aspectsJ Clin Invest19837227076409929
  • UnnoTTagoMSuzukiYEffect of tea catechins on postprandial plasma lipid responses in human subjectsBr J Nutr200593543715946418
  • UrsiniFZamburliniACazzolatoGPostprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosisFree Rad Biol Med19982525029667503
  • VaccaroORuffaGImperatoreGRisk of diabetes in the new diagnostic category of impaired fasting glucoseDiabetes Care1999221490310480514
  • Van De BornePHausbergMHoffmanRPHyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjectsAm J Physiol1999276R178839887192
  • Van OostromAJHHMSijmonsmaTPRabelinkTJPostprandial leukocyte increase in healthy subjectsMetabolism20035219920212601632
  • WannametheeSGLoweGDOShaperAGInsulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart diseaseDiabetologia20044715576515365613
  • WhitesideCICellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen speciesCurr Hypertens Rep200571485415748541
  • XieHLauttWWInduction of insulin resistance by cholinergic blockade with atropine in the catJ Auton Pharmacol19951536198744976
  • XieHLauttWWInsulin resistance of skeletal muscle produced by hepatic parasympathetic interruptionAm J Physiol1996a270E858638967475
  • XieHLauttWWInsulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administrationAm J Physiol1996b271E587928843755
  • XieHTsybenkoVAJohnsonMVInsulin resistance of glucose response produced by hepatic denervationsCan J Physiol Pharmacol19937117588319140
  • ZetheliusBLithellHHalesCNInsulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year-old men using the euglycaemic insulin clampDiabetologia200548862715803331
  • ZilversmitDBAtherogenesis: a post-prandial phenomenonCirculation19796047385222498
  • ZsugaJToryKJaszlitsLPre-clinical methods for the determination of insulin sensitivityJ Biochem Biophys Meth200461253815560942